Positive Results Propel Scinai (SCNI) Stock Surge Today
This morning, Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) witnessed a remarkable surge in stock price, soaring by 60.59% to $6.52, following the announcement of promising clinical study outcomes. Innovative NanoAb Treatment Targets Mild to Moderate Plaque Psoriasis Scinai revealed successful in-vivo preclinical study results of its groundbreaking anti IL-17A/F VHH antibody fragment, branded as ‘NanoAb’. This […]